Literature DB >> 25639301

Drug induced pulmonary parenchymal disease.

Rajendra Prasad1, Pawan Gupta, Abhijeet Singh, Nitin Goel.   

Abstract

Drug-induced pulmonary parenchymal disease (DIPPD) can be caused by a variety of agents, including antibiotics, chemotherapeutic drugs, antiarrhythmic agents and non-steroidal anti-inflammatory drugs (NSAIDs). DIPPD includes acute bronchospasm, organizing pneumonia, alveolar hypoventilation and hypersensitivity reactions. History, physical examination and investigations are required mainly to exclude other causes of lung diseases. Investigations may include chest radiography, pulmonary function testing and bronchoscopy with bronchoalveolar lavage (BAL). Recognition of DIPPD is difficult because the clinical, radiologic, and histologic findings are nonspecific. Management includes drug withdrawal and in some cases corticosteroid therapy. In this article we reviewed the various drugs known to cause pulmonary parenchymal diseases, various patterns of parenchymal diseases observed and their management.

Entities:  

Mesh:

Year:  2014        PMID: 25639301     DOI: 10.5582/ddt.2014.01046

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  6 in total

Review 1.  Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

2.  Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma - A case report.

Authors:  R Kuint; M Lotem; T Neuman; E Bekker-Milovanov; A Abutbul; U Laxer; N Berkman; Z G Fridlender
Journal:  Respir Med Case Rep       Date:  2017-01-12

3.  A case of non-cardiogenic pulmonary edema provoked by intravenous acetazolamide.

Authors:  Yuichiro Ono; Makiko Morifusa; Satoru Ikeda; Chika Kunishige; Yoshiki Tohma
Journal:  Acute Med Surg       Date:  2017-04-24

Review 4.  HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review.

Authors:  Giulio Distefano; Luigi Fanzone; Monica Palermo; Francesco Tiralongo; Salvatore Cosentino; Corrado Inì; Federica Galioto; Ada Vancheri; Sebastiano E Torrisi; Letizia A Mauro; Pietro V Foti; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2020-04-22

Review 5.  NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.

Authors:  Ozlem Cavkaytar; Mustafa Arga
Journal:  J Asthma Allergy       Date:  2022-09-28

Review 6.  A case report and literature review: previously excluded tuberculosis masked by amiodarone induced lung injury.

Authors:  Egle Karinauske; Silvijus Abramavicius; Greta Musteikiene; Edgaras Stankevicius; Jurgita Zaveckiene; Vidas Pilvinis; Edmundas Kadusevicius
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-29       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.